Popular Inc. logo

Popular Inc. (BPOP)

Market Open
4 Jun, 18:24
NASDAQ (NGS) NASDAQ (NGS)
$
152. 92
+4.79
+3.2336%
$
9.72B Market Cap
11 P/E Ratio
2.48% Div Yield
183,837 Volume
8.6 Eps
$ 148.13
Previous Close
Add Transaction
Day Range
149.53 153.06
Year Range
102.56 153.22
Want to track BPOP and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Does Nvidia Know Something Wall Street Doesn't? The Chipmaker Just Sold 4 Popular Artificial Intelligence (AI) Stocks and Bought 2 Others.

Does Nvidia Know Something Wall Street Doesn't? The Chipmaker Just Sold 4 Popular Artificial Intelligence (AI) Stocks and Bought 2 Others.

Advances in the field of artificial intelligence (AI) over the past couple of years have come fast and furious. Arguably, one of the biggest beneficiaries of this trend is Nvidia (NVDA 0.40%).

Fool | 1 year ago
Series A Preferred Shares Of Popular, Inc. Offer Stable Monthly Income

Series A Preferred Shares Of Popular, Inc. Offer Stable Monthly Income

Popular, Inc.'s Series A Preferred Shares offer a yield near 6.5% with monthly dividends that have been paid without interruption for more than 20 years. Puerto Rican banks, including Popular, Inc., benefit from an oligopolistic market. Popular, Inc. has improved several financial metrics since I last covered its Series A Preferred Shares in 2020.

Seekingalpha | 1 year ago
Popular weight-loss drug helps to reduce alcohol consumption and smoking, new study finds

Popular weight-loss drug helps to reduce alcohol consumption and smoking, new study finds

Ozempic and other semaglutide drugs help people reduce their drinking, a new study has found.

News | 1 year ago
3 Wildly Popular Dividend Stocks I Won't Be Buying

3 Wildly Popular Dividend Stocks I Won't Be Buying

I focus on finding great stocks rather than avoiding bad ones - good investments are rare, while weak stocks are easy to spot. This approach adds more value. Bearish articles often lead to defensive reactions rather than insightful discussions. I prefer constructive engagement, making my analysis more valuable to readers. That said, I highlight a few well-known dividend stocks I would avoid. My goal isn't to convince anyone to sell, but to provide food for thought and perspective.

Seekingalpha | 1 year ago
2 Popular AI Stocks to Sell Before They Fall 65% and 73%, According to Certain Wall Street Analysts

2 Popular AI Stocks to Sell Before They Fall 65% and 73%, According to Certain Wall Street Analysts

Palantir Technologies (PLTR 23.99%) and Tesla (TSLA 2.22%) were two of the most popular stocks among retail investors last year as measured by net inflows. But most Wall Street analysts expect both stocks to decline this year.

Fool | 1 year ago
Can This Popular Vanguard Tech ETF Trounce the S&P 500 Again in 2025?

Can This Popular Vanguard Tech ETF Trounce the S&P 500 Again in 2025?

Exchange-traded funds (ETFs) have transformed the investing landscape since their 1993 debut, attracting investors with their straightforward approach to diversification. By allowing individuals to buy shares that track entire market indexes or sectors, ETFs eliminate the challenge and risk of selecting individual stocks while keeping costs minimal.

Fool | 1 year ago
Popular Q4 Earnings & Revenues Beat on Higher NII, Provisions Fall Y/Y

Popular Q4 Earnings & Revenues Beat on Higher NII, Provisions Fall Y/Y

A rise in NII, along with higher loan and deposit balances, aids BPOP's Q4 earnings. Yet, a rise in costs and a fall in fee income are headwinds.

Zacks | 1 year ago
Popular, Inc. (BPOP) Q4 2024 Earnings Conference Call Transcript

Popular, Inc. (BPOP) Q4 2024 Earnings Conference Call Transcript

Popular, Inc. (BPOP) Q4 2024 Earnings Conference Call Transcript

Seekingalpha | 1 year ago
Ozempic Approved By FDA For Kidney Disease—In Ultra-Popular Drug's Latest Approval

Ozempic Approved By FDA For Kidney Disease—In Ultra-Popular Drug's Latest Approval

The Food and Drug Administration approved Ozempic for treating patients with chronic kidney disease on Tuesday, marking the latest authorized use for Novo Nordisk's popular drug known for diabetes and weight loss.

Forbes | 1 year ago
Popular (BPOP) Q4 Earnings and Revenues Surpass Estimates

Popular (BPOP) Q4 Earnings and Revenues Surpass Estimates

Popular (BPOP) came out with quarterly earnings of $2.51 per share, beating the Zacks Consensus Estimate of $2.04 per share. This compares to earnings of $1.94 per share a year ago.

Zacks | 1 year ago
2 Popular Quantum Computing Stocks Could Drop 52% and 77%, According to Wall Street

2 Popular Quantum Computing Stocks Could Drop 52% and 77%, According to Wall Street

Alphabet subsidiary Google recently announced two major technical achievements with its Willow quantum computing chip. In response to the news, shares of Rigetti Computing (RGTI -3.16%) and D-Wave Quantum (QBTS -3.52%) during the next three weeks advanced 280% and 110%, respectively.

Fool | 1 year ago
Popular (BPOP) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Popular (BPOP) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Popular (BPOP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks | 1 year ago
Loading...
Load More